Heligenics Inc. was formed to implement the GigaAssay to produce saturating mutation/function maps for key genes already established for both inherited disease and cancer diagnostics, or associated with actionable therapies.
The GigaAssay technology was developed at the University of Nevada Las Vegas in the Schiller Laboratory of Applied Bioinformatics. As a massively parallel biological assay that can simultaneously measure how millions of genetic variants or other sequence variables affect the molecular function of cell process, this would take many years if not decades to accomplish using conventional methods. To date, there are no other established assays that assess cell processes and molecular functions in human cells at this kind of scale.
